Slovenia | Imports and Exports | World | Pharmaceutical products | Value (US$) and Value Growth, YoY (%) | 2012 - 2023
The value of exports of commodity group 30 "Pharmaceutical products" from Slovenia totalled $ 20 billion in 2023. Sales of commodity group 30 from Slovenia went up by 31% compared to 2022: exports of commodity group 30 "Pharmaceutical products" went up by $ 4.85 billion (cumulative exports of commodity group 30 from Slovenia amounted $15.2 billion in 2022)
Exports of commodity group 30 "Pharmaceutical products" amounted to 33% of total exports from Slovenia (cumulative merchandise exports from Slovenia totalled $ 59 billion in 2023). The share of commodity group 30 in total exports from Slovenia increased by 6.2 p.p. compared to 2022 (it was 27% in 2022 and cumulative exports from Slovenia were equal to $ 55 billion).
Where does Slovenia export Pharmaceutical products?
Top export destinations of "Pharmaceutical products" from Slovenia in 2023:
- Switzerland with a share of 75% (15.2 billion US$)
- Russia with a share of 3.26% (657 million US$)
- Germany with a share of 1.71% (344 million US$)
- Croatia with a share of 1.71% (344 million US$)
- Poland with a share of 1.42% (286 million US$)
- Serbia with a share of 1.17% (237 million US$)
- Bulgaria - 163 million US$
- Romania - 157 million US$
- Slovak Republic - 148 million US$
- Czech Republic - 143 million US$
Exports structure of 30 - Pharmaceutical products - from Slovenia in 2023 represented by the following main commodity groups:
- 92% (18.5 billion US$): 3004 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale
- 6.97% (1.4 billion US$): 3002 - Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc
- 0.487% (98 million US$): 3003 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale
- 0.277% (56 million US$): 3006 - Pharmaceutical goods specified in Note 4 to this Chapter.
- 0.042% (8.66 million US$): 3005 - Wadding, gauze, bandages and similar articles (for example, dressings, adhesive plasters, poultices), impregnated or coated with pharmaceutical substances or put up in forms or packings for retail sale for medical, surgical, dental or veterinary purposes.
- 0% (35 thousand US$): 3001 - Glands, organs (extracts, secretions thereof) for organo-therapeutic uses, dried, powdered or not; heparin and its salts; other human or animal substances for therapeutic or prophylactic uses n.e.s.
The value of imports of commodity group 30 "Pharmaceutical products" to Slovenia totalled $ 8.72 billion in 2023. Sales of commodity group 30 to Slovenia decreased by 3.05% in value terms compared to 2022. imports of commodity group 30 "Pharmaceutical products" decreased by $ 275 million (the value of imports of commodity group 30 to Slovenia was equal to $9 billion in 2022)
Imports of commodity group 30 "Pharmaceutical products" accounted for 14.1% of total import flow to Slovenia (in 2023, total imports to Slovenia amounted to $ 61 billion). The share of commodity group 30 in total imports to Slovenia decreased by 0.963 p.p. compared to 2022 (it was 15.1% in 2022 and cumulative imports to Slovenia were equal to $ 59 billion).
Where does Slovenia import Pharmaceutical products from?
Top trading partners (import of "Pharmaceutical products") of Slovenia in 2023:
- Switzerland with a share of 70% (6.15 billion US$)
- Germany with a share of 5.65% (493 million US$)
- USA with a share of 4.1% (358 million US$)
- France with a share of 2.48% (216 million US$)
- Singapore with a share of 2.23% (194 million US$)
- Ireland with a share of 1.98% (172 million US$)
- Austria with a share of 1.9% (165 million US$)
- Italy with a share of 1.47% (128 million US$)
- India with a share of 1.15% (100 million US$)
- Spain - 75 million US$
Imports structure of 30 - Pharmaceutical products - to Slovenia in 2023 represented by the following main commodity groups:
- 86% (7.53 billion US$): 3004 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale
- 12.5% (1.09 billion US$): 3002 - Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc
- 0.778% (67 million US$): 3006 - Pharmaceutical goods specified in Note 4 to this Chapter.
- 0.196% (17.1 million US$): 3005 - Wadding, gauze, bandages and similar articles (for example, dressings, adhesive plasters, poultices), impregnated or coated with pharmaceutical substances or put up in forms or packings for retail sale for medical, surgical, dental or veterinary purposes.
- 0.093% (8.14 million US$): 3003 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale
- 0.011% (1 million US$): 3001 - Glands, organs (extracts, secretions thereof) for organo-therapeutic uses, dried, powdered or not; heparin and its salts; other human or animal substances for therapeutic or prophylactic uses n.e.s.
